tiprankstipranks
United Therapeutics (UTHR)
NASDAQ:UTHR
US Market

United Therapeutics (UTHR) Income Statement

Compare
561 Followers

United Therapeutics Income Statement

Last quarter (Q4 2024), United Therapeutics's total revenue was $735.90M, an increase of 19.72% from the same quarter last year. In Q4, United Therapeutics's net income was $301.30M. See United Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.88B$ 2.33B$ 1.94B$ 1.69B$ 1.48B
Gross Profit
$ 2.57B$ 2.07B$ 1.79B$ 1.56B$ 1.38B
Operating Expenses
$ 1.19B$ 885.10M$ 809.90M$ 1.01B$ 781.60M
Depreciation and Amortization
$ 72.50M$ 53.20M$ 51.30M$ 49.90M$ 49.90M
EBITDA
$ 1.65B$ 1.39B$ 1.04B$ 736.80M$ 646.30M
Operating Income
$ 1.38B$ 1.18B$ 979.70M$ 555.90M$ 593.60M
Other Income/Expenses
$ 162.00M$ 89.40M$ -29.10M$ 38.00M$ 45.30M
Pretax Income
$ 1.54B$ 1.27B$ 950.60M$ 593.90M$ 638.90M
Net Income
$ 1.20B$ 984.80M$ 727.30M$ 475.80M$ 514.80M
Per Share Metrics
Basic EPS
$ 26.44$ 21.04$ 15.98$ 10.60$ 11.65
Diluted EPS
$ 24.64$ 19.81$ 15.00$ 10.06$ 11.54
Weighted Average Shares Outstanding
45.20M 46.80M 45.50M 44.90M 44.20M
Weighted Average Shares Outstanding (Diluted)
48.50M 49.70M 48.50M 47.30M 44.60M
Currency in USD

United Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis